Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide added to insulin infusion vs insulin alone for glucose control in diabetic patients undergoing cardiac surgery
TCTR20190118012Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Chulalongkorn University. Started May 2018; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20190118012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190118012.